OPA1 and ovarian carcinoma: We highlight, in the heterogeneity of ovarian cancer, a characteristic “mitochondrial signature”, characterized by increased mitochondrial biogenesis and altered mitochondrial structure that could result from the cooperation of cAMP pathway and the SIRT3, OPA1, and PHB2 proteins.